Get answers for your health queries from top Doctors for FREE!

100% Privacy Protection

100% Privacy Protection

We maintain your privacy and data confidentiality.

Verified Doctors

Verified Doctors

All Doctors go through a stringent verification process.

Quick Response

Quick Response

All Doctors go through a stringent verification process.

Reduce Clinic Visits

Reduce Clinic Visits

Save your time and money from the hassle of visits.

Ask Free Question

  1. Home >
  2. Blogs >
  3. Stem Cell Treatment for Ovarian Cancer
  • Cancer
  • Stem Cell

Stem Cell Treatment for Ovarian Cancer

By Priyanka Dutta Deb| Last Updated at: 6th Sept '24| 16 Min Read

Ovarian cancer is a serious and often deadly disease that affects thousands of women in India and across the globe. In India, ovarian cancer ranks as the third most common cancer among women, with over 36,000 new cases diagnosed annually. The disease primarily affects women over the age of 50, but it can occur at any age. Ovarian cancer begins in the ovaries, which are responsible for producing eggs and hormones like estrogen and progesterone. The disease is often diagnosed at an advanced stage, making it difficult to treat with conventional therapies.

Stem cell ovarian cancer treatment is emerging as a promising approach to combat this disease. This article explores the potential of stem cell therapy in treating ovarian cancer, its benefits, risks, costs, and where you can access this treatment in India. It also addresses whether stem cells can cure ovarian cancer, including Stage 4, and delves into the FDA approval status.

What is Stem Cell Ovarian Cancer Treatment?

Stem cell ovarian cancer treatment involves using stem cells to repair or replace damaged cells in the ovaries. Stem cells are unique because they can develop into different types of cells in the body. In ovarian cancer, stem cells can regenerate healthy ovarian tissue, target and kill cancerous cells, or boost the immune system to fight the disease.

There are different types of stem cells used in cancer treatment, including hematopoietic stem cells (which give rise to blood cells) and mesenchymal stem cells (which can develop into bone, cartilage, and fat cells). The choice of stem cell type depends on the specific treatment plan.

Can Stem Cells Cure Ovarian Cancer?

The question of whether stem cells can cure ovarian cancer is complex. While stem cell therapy is promising, it is not yet a definitive cure. Current research focuses on understanding how stem cells can target and eliminate cancerous cells and how they can aid in regenerating healthy ovarian tissue.

Recent studies have shown that stem cells can differentiate into various ovarian cell types, potentially replacing damaged tissue and improving ovarian function. However, more research is needed to determine the long-term efficacy and safety of these treatments. Stem cell ovarian cancer treatment is still in its experimental stages, and while early results are encouraging, it is not yet a guaranteed cure.

Is There a Cure for Stage 4 Ovarian Cancer?

Stage 4 ovarian cancer is the most advanced stage of the disease, where cancer has spread to distant organs such as the liver, lungs, or lymph nodes. Unfortunately, Stage 4 ovarian cancer is difficult to treat, and the prognosis is generally poor. However, stem cell transplant for ovarian cancer offers new hope for patients with advanced disease.

Stem cell therapy aims to target and destroy ovarian cancer stem cells, which are believed to play a key role in the spread and recurrence of the disease. By eliminating these cells, stem cell therapy could potentially slow or stop the progression of Stage 4 ovarian cancer. While a complete cure may not yet be achievable, stem cell treatment offers a promising option for extending life and improving the quality of life for patients with advanced ovarian cancer.

Where Can I Get Stem Cell Ovarian Cancer Treatment in India?

India is home to several leading hospitals and research centers offering ovarian cancer stem cell treatment. Here are ten hospitals where you can access cutting-edge therapies:

StemRX Bioscience Solutions, Mumbai

NeuroGen Brain and Spine Institute, Navi Mumbai

  • NeuroGen specializes in regenerative medicine and offers comprehensive stem cell treatments for various cancers, including ovarian cancer. Their multidisciplinary approach combines stem cell therapy with rehabilitation to improve patient outcomes.

Tata Memorial Hospital, Mumbai

  • A leading cancer treatment center in India, Tata Memorial Hospital offers a range of advanced therapies, including stem cell transplants. Their research division is involved in clinical trials for stem cell ovarian cancer treatment.

All India Institute of Medical Sciences (AIIMS), New Delhi

  • AIIMS is a premier medical research institute in India, providing cutting-edge treatments for ovarian cancer, including hematopoietic stem cell transplants. AIIMS is also involved in research on ovarian cancer stem cell markers and their role in disease progression.

Fortis Memorial Research Institute, Gurgaon

  • Fortis offers a comprehensive cancer care program, including stem cell therapy for ovarian cancer. Their state-of-the-art facilities and experienced oncologists provide personalized treatment plans for patients.

Apollo Hospitals, Chennai

  • Apollo Hospitals is known for its advanced cancer treatment programs, including stem cell transplants. Their oncology department is equipped with the latest technology and expertise in ovarian cancer treatment.

Max Super Specialty Hospital, Delhi

  • Max Hospital offers a range of advanced cancer treatments, including stem cell therapy for ovarian cancer. Their team of specialists focuses on providing personalized care to improve patient outcomes.

Christian Medical College (CMC), Vellore

  • CMC Vellore is a leading medical institution in India. It offers stem cell therapy for various cancers, including ovarian cancer. The research team is actively involved in studying the role of stem cells in cancer treatment.

Medanta – The Medicity, Gurgaon

  • Medanta is a multi-speciality hospital offering comprehensive cancer care, including stem cell transplants. Their oncology department is equipped with the latest technology and expertise in ovarian cancer treatment.

Manipal Hospital, Bangalore

  • Manipal Hospital offers advanced cancer treatment options, including stem cell therapy for ovarian cancer. Their multidisciplinary team provides personalized care to improve patient outcomes.

What Are the Benefits of Stem Cell Ovarian Cancer Treatment?

Stem cell ovarian cancer treatment offers several potential benefits, including:

  • Targeted Therapy: Stem cells can be engineered to target and kill cancerous cells while sparing healthy tissue, reducing the side effects of treatment.
  • Tissue Regeneration: Stem cells can regenerate damaged ovarian tissue, potentially restoring normal ovarian function.
  • Immune System Boost: Stem cell therapy can enhance the immune system’s ability to fight cancer by introducing healthy, functional cells.
  • Reduced Recurrence: Stem cell therapy may reduce the risk of cancer recurrence by targeting ovarian cancer stem cells.

What Are the Risks of Stem Cell Ovarian Cancer Treatment?

While stem cell therapy offers promising benefits, it also carries certain risks:

  • Tumour Formation: If stem cells do not differentiate properly, they could form tumours, known as teratomas.
  • Immune Rejection: The body’s immune system may reject the transplanted stem cells, leading to complications.
  • Infection: The process of stem cell transplantation can weaken the immune system, increasing the risk of infection.
  • Unknown Long-Term Effects: Stem cell therapy is still relatively new, so its long-term effects are not fully understood.

What is the Cost of Stem Cell Ovarian Cancer Treatment?

The cost of stem cell ovarian cancer treatment in India can vary widely depending on the type of stem cells used, the hospital, and the complexity of the treatment. On average, the cost can range from I8000 USD to 12000 USD. This cost typically includes the stem cell transplant procedure, hospitalization, and follow-up care. It is important to consult with the hospital and your healthcare provider to get an accurate estimate based on your specific treatment plan.

FDA Approval Status of Stem Cell Ovarian Cancer Treatment

As of now, stem cell treatment for ovarian cancer has not received full FDA approval. While there are ongoing clinical trials and research studies, the therapy is still considered experimental. The FDA has approved certain types of stem cell transplants, such as hematopoietic stem cell transplants, for specific conditions but not specifically for ovarian cancer. Patients considering stem cell therapy should know its experimental nature and discuss the potential risks and benefits with their healthcare provider.

Stem cell ovarian cancer treatment is an exciting and rapidly evolving field that offers new hope for patients battling this challenging disease. While the therapy is still in its experimental stages, early results are promising, particularly for patients with advanced-stage ovarian cancer. By targeting ovarian cancer stem cells and regenerating healthy tissue, stem cell therapy can potentially improve patient outcomes and quality of life.

However, it is important to recognize that stem cell therapy is not yet guaranteed cure, and more research is needed to understand its long-term effects and efficacy fully. Patients considering this treatment should consult with their healthcare provider to weigh the potential benefits and risks and to explore all available options.

Related Blogs

Question and Answers

. Heterogeneous Soft Tissue Nodule in the Right Lower Lobe (RLL) Size: 14 x 8 mm This nodule is described as heterogeneously enhancing, which suggests it may have varying levels of blood flow or different tissue densities within it. This could be indicative of a tumor. 2. Air Space Opacification in the Right Upper Lobe (RUL) Finding: There is patchy air space opacification with interlobular septal thickening in the posterior segment of RUL. This could represent infection, inflammation, or more concerningly, metastatic disease or lung cancer causing these changes. 3. Left-sided Pleural Effusion and Subsegmental Atelectasis Pleural Effusion: Mild left-sided pleural effusion is noted. Pleural effusion can occur in the context of metastatic disease or cancer. Atelectasis: This refers to partial lung collapse, which may occur when there is a mass obstructing the airflow or due to pleural fluid. 4. Enlarged Mediastinal and Hilar Lymph Nodes Lymphadenopathy: There are multiple enlarged and necrotic lymph nodes, most notably in the right hilar region, with the largest measuring 35 x 25 mm. Enlargement and necrosis of lymph nodes can be a sign of metastatic spread. The presence of enlarged lymph nodes in the mediastinum and hilum is typical of malignancy spreading beyond the primary lung site. 5. Liver Lesion Size: 14 x 13 mm lesion in the right hepatic lobe, which is well-defined and peripherally enhancing. A hypodense lesion could indicate a metastatic tumor, especially since it shows peripheral enhancement, a characteristic of some types of metastases. 6. Skeletal Lesions Multiple Lesions: There are mixed lytic and sclerotic bony lesions, some with soft tissue components. These lesions involve the vertebrae, ribs, glenoids, sternum, sacral ala, iliac bones, and femur. Soft Tissue Components: Some of the lesions, such as those in the ribs and iliac bones, have a soft tissue component, which suggests more advanced involvement, possibly indicating metastases. 7. Other Findings: No signs of emphysema, bronchiectasis, or pneumothorax were noted, which is reassuring as it reduces the likelihood of certain types of lung diseases. The liver, spleen, pancreas, kidneys, urinary bladder, and prostate all appear normal on imaging, which helps to rule out major issues in these organs. Impression: The findings of a heterogeneously enhancing solitary pulmonary nodule in the right lung, with associated hilar and mediastinal lymphadenopathy, along with a hepatic lesion and extensive skeletal involvement (with mixed lytic and sclerotic lesions), strongly raise concern for metastatic disease, most likely originating from the lung. The primary lung cancer is a potential consideration, though other primary sites are also possible. Next Steps: Histopathological correlation: This means a biopsy or tissue sample should be taken from one of the lesions (pulmonary, hepatic, or bone) to confirm whether the lesions are malignant and, if so, to identify the type of cancer. This will help determine the best course of treatment. The overall picture suggests a metastatic malignancy, likely of pulmonary origin, but further investigations and biopsy are essential to establish a definitive diagnosis and treatment plan.

Male | 58

Answered on 8th Mar '25

Read answer

Cancer Hospitals In Other Cities

Top Related Speciality Doctors In Other Cities

Cost Of Related Treatments In Country

Consult